Sitemap
- Welcome to singular mAb experience
- Ready-to-use mAbs
- Secondary antibodies : anti – mouse Ig
- Secondary antibodies : anti – rat Ig
- Secondary antibodies : anti – human Ig
- Conjugates : anti-HRP, anti-FITC & Biotin mAbs
- IgG isotype controls
- Anti-toxins mAbs
- Anti-species mAbs
- Negative control Ig
- Irrelevant Ig : anti-DNP
- Anti-human mAbs : cytokines, leucocytes and HIV
- Distributors of SynAbs mAbs catalogue
- Custom monoclonal antibody development
- Rat Monoclonal Antibodies
- Guinea pig Monoclonal Antibodies
- About SynAbs
- Contact SynAbs
Blog
- 09/05/2017 - SynAbs widens its team to sustain organic growth
- 06/21/2017 - SynAbs attended Pivotal Scientific congress in Oxford!
- 06/01/2017 - SynAbs moves its facilities to Gosselies BioPark
- 05/24/2017 - SynAbs attended BioMed congress in Israël!
- 05/18/2017 - SynAbs attended Knowledge for Growth event in Ghent!
- 05/10/2017 - SynAbs attended WBC 10th anniversary as special guest!
- 05/05/2017 - SynAbs inks agreement with Sapphire as new distributor for its unique catalogue of monoclonal antibodies in USA & Canada
- 01/13/2017 - SynAbs inks agreement with Dianova GmbH as new distributor for its unique catalogue of monoclonal antibodies in Germany
- 09/19/2016 - SynAbs appoints LuBioScience GmbH as new distributor for its unique catalogue of monoclonal antibodies in Switzerland
- 08/03/2016 - Guinea pig monoclonal antibodies : a new promising tool for R&D, IVD and therapeutics
- 08/03/2016 - The small molecule detection challenge : the aflatoxin case study
- 01/28/2016 - SynAbs brings rats to antibody market
- 09/01/2015 - SynAbs set-up, a new rat mAb expert on the marketplace
SynAbs S.A.
Rue Auguste Piccard, 48
I-Tech Incubator 2, Aile Piccard, +1
B-6041 Gosselies
Belgium
Tel +32 71/374.880